April 9, 2017 Intec Pharma Appoints U.S. Life Sciences Executive Jeffrey A. Meckler to its Board of Directors as Vice Chairman View Article
March 22, 2017 Intec Pharma Initiates Phase I Trial of Accordion Pill for Cannabinoid Therapies View Article
November 28, 2016 Intec Pharma Enters into Agreement with the Michael J. Fox Foundation Around Its Phase III Trial Recruitment View Article
August 4, 2016 Intec Pharma to Pursue Development of Accordion Pill for Cannabinoid Therapies View Article
April 4, 2016 Intec Pharma (NTEC) Announces Enrollment of First Patient in Pivotal AP-CDLD Phase 3 View Article
December 16, 2015 Intec Pharma Ltd. Further Expands Intellectual Property With A New Patent For The Accordion Pill Zaleplon In Europe View Article
